Shopping Cart 0
Cart Subtotal
USD 0

Global Neoantigen Targeted Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 4880

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 7320

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 9760

Details

Description

Scope of the Report:

The global Neoantigen Targeted Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neoantigen Targeted Therapies.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Neoantigen Targeted Therapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neoantigen Targeted Therapies market by product type and applications/end industries.

Market Segment by Companies, this report covers

Bavarian Nordic

Neon Therapeutics

Immunicum

Genocea Biosciences

MediGene

Gradalis

Iovance Biotherapeutics

Immunovative Therapies

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monotherapy

Combination Therapy

Market Segment by Applications, can be divided into

Medical Research Institution

Hospital and Clinic

Other

READ MORE

Table Of Content

Scope

Table of Contents

1 Neoantigen Targeted Therapies Market Overview

1.1 Product Overview and Scope of Neoantigen Targeted Therapies

1.2 Classification of Neoantigen Targeted Therapies by Types

1.2.1 Global Neoantigen Targeted Therapies Revenue Comparison by Types (2019-2024)

1.2.2 Global Neoantigen Targeted Therapies Revenue Market Share by Types in 2018

1.2.3 Monotherapy

1.2.4 Combination Therapy

1.3 Global Neoantigen Targeted Therapies Market by Application

1.3.1 Global Neoantigen Targeted Therapies Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Medical Research Institution

1.3.3 Hospital and Clinic

1.3.4 Other

1.4 Global Neoantigen Targeted Therapies Market by Regions

1.4.1 Global Neoantigen Targeted Therapies Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.5 Global Market Size of Neoantigen Targeted Therapies (2014-2024)

2 Company Profiles

2.1 Bavarian Nordic

2.1.1 Business Overview

2.1.2 Neoantigen Targeted Therapies Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bavarian Nordic Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.2 Neon Therapeutics

2.2.1 Business Overview

2.2.2 Neoantigen Targeted Therapies Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Neon Therapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.3 Immunicum

2.3.1 Business Overview

2.3.2 Neoantigen Targeted Therapies Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Immunicum Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.4 Genocea Biosciences

2.4.1 Business Overview

2.4.2 Neoantigen Targeted Therapies Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Genocea Biosciences Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.5 MediGene

2.5.1 Business Overview

2.5.2 Neoantigen Targeted Therapies Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 MediGene Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.6 Gradalis

2.6.1 Business Overview

2.6.2 Neoantigen Targeted Therapies Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Gradalis Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.7 Iovance Biotherapeutics

2.7.1 Business Overview

2.7.2 Neoantigen Targeted Therapies Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.8 Immunovative Therapies

2.8.1 Business Overview

2.8.2 Neoantigen Targeted Therapies Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Immunovative Therapies Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

3 Global Neoantigen Targeted Therapies Market Competition, by Players

3.1 Global Neoantigen Targeted Therapies Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Neoantigen Targeted Therapies Players Market Share

3.2.2 Top 10 Neoantigen Targeted Therapies Players Market Share

3.3 Market Competition Trend

4 Global Neoantigen Targeted Therapies Market Size by Regions

4.1 Global Neoantigen Targeted Therapies Revenue and Market Share by Regions

4.2 North America Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.3 Europe Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.5 South America Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

5 North America Neoantigen Targeted Therapies Revenue by Countries

5.1 North America Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

5.2 USA Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

5.3 Canada Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

5.4 Mexico Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6 Europe Neoantigen Targeted Therapies Revenue by Countries

6.1 Europe Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

6.2 Germany Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.3 UK Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.4 France Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.5 Russia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.6 Italy Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Neoantigen Targeted Therapies Revenue by Countries

7.1 Asia-Pacific Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

7.2 China Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.3 Japan Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.4 Korea Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.5 India Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

8 South America Neoantigen Targeted Therapies Revenue by Countries

8.1 South America Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

8.2 Brazil Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

8.3 Argentina Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

8.4 Colombia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Neoantigen Targeted Therapies by Countries

9.1 Middle East and Africa Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

9.2 Saudi Arabia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.3 UAE Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.4 Egypt Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.5 Nigeria Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.6 South Africa Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

10 Global Neoantigen Targeted Therapies Market Segment by Type

10.1 Global Neoantigen Targeted Therapies Revenue and Market Share by Type (2014-2019)

10.2 Global Neoantigen Targeted Therapies Market Forecast by Type (2019-2024)

10.3 Monotherapy Revenue Growth Rate (2014-2024)

10.4 Combination Therapy Revenue Growth Rate (2014-2024)

11 Global Neoantigen Targeted Therapies Market Segment by Application

11.1 Global Neoantigen Targeted Therapies Revenue Market Share by Application (2014-2019)

11.2 Neoantigen Targeted Therapies Market Forecast by Application (2019-2024)

11.3 Medical Research Institution Revenue Growth (2014-2019)

11.4 Hospital and Clinic Revenue Growth (2014-2019)

11.5 Other Revenue Growth (2014-2019)

12 Global Neoantigen Targeted Therapies Market Size Forecast (2019-2024)

12.1 Global Neoantigen Targeted Therapies Market Size Forecast (2019-2024)

12.2 Global Neoantigen Targeted Therapies Market Forecast by Regions (2019-2024)

12.3 North America Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.4 Europe Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.6 South America Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Figure

List of Tables and Figures

Figure Neoantigen Targeted Therapies Picture

Table Product Specifications of Neoantigen Targeted Therapies

Table Global Neoantigen Targeted Therapies and Revenue (Million USD) Market Split by Product Type

Figure Global Neoantigen Targeted Therapies Revenue Market Share by Types in 2018

Figure Monotherapy Picture

Figure Combination Therapy Picture

Table Global Neoantigen Targeted Therapies Revenue (Million USD) by Application (2014-2024)

Figure Neoantigen Targeted Therapies Revenue Market Share by Applications in 2018

Figure Medical Research Institution Picture

Figure Hospital and Clinic Picture

Figure Other Picture

Table Global Market Neoantigen Targeted Therapies Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Table Bavarian Nordic Basic Information, Manufacturing Base and Competitors

Table Bavarian Nordic Neoantigen Targeted Therapies Type and Applications

Table Bavarian Nordic Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Neon Therapeutics Basic Information, Manufacturing Base and Competitors

Table Neon Therapeutics Neoantigen Targeted Therapies Type and Applications

Table Neon Therapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Immunicum Basic Information, Manufacturing Base and Competitors

Table Immunicum Neoantigen Targeted Therapies Type and Applications

Table Immunicum Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Genocea Biosciences Basic Information, Manufacturing Base and Competitors

Table Genocea Biosciences Neoantigen Targeted Therapies Type and Applications

Table Genocea Biosciences Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table MediGene Basic Information, Manufacturing Base and Competitors

Table MediGene Neoantigen Targeted Therapies Type and Applications

Table MediGene Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Gradalis Basic Information, Manufacturing Base and Competitors

Table Gradalis Neoantigen Targeted Therapies Type and Applications

Table Gradalis Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Iovance Biotherapeutics Basic Information, Manufacturing Base and Competitors

Table Iovance Biotherapeutics Neoantigen Targeted Therapies Type and Applications

Table Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Immunovative Therapies Basic Information, Manufacturing Base and Competitors

Table Immunovative Therapies Neoantigen Targeted Therapies Type and Applications

Table Immunovative Therapies Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Global Neoantigen Targeted Therapies Revenue (Million USD) by Players (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue Share by Players (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Share by Players in 2017

Figure Global Neoantigen Targeted Therapies Revenue Share by Players in 2018

Figure Global Top 5 Players Neoantigen Targeted Therapies Revenue Market Share in 2018

Figure Global Top 10 Players Neoantigen Targeted Therapies Revenue Market Share in 2018

Figure Global Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue (Million USD) by Regions (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue Market Share by Regions (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Market Share by Regions (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Market Share by Regions in 2018

Figure North America Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Europe Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure South America Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table North America Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

Table North America Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure North America Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure North America Neoantigen Targeted Therapies Revenue Market Share by Countries in 2018

Figure USA Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Canada Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Mexico Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table Europe Neoantigen Targeted Therapies Revenue (Million USD) by Countries (2014-2019)

Figure Europe Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure Europe Neoantigen Targeted Therapies Revenue Market Share by Countries in 2018

Figure Germany Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure UK Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure France Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Russia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Italy Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Neoantigen Targeted Therapies Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Neoantigen Targeted Therapies Revenue Market Share by Countries in 2018

Figure China Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Japan Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Korea Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure India Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table South America Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

Table South America Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure South America Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure South America Neoantigen Targeted Therapies Revenue Market Share by Countries in 2018

Figure Brazil Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Argentina Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Colombia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Neoantigen Targeted Therapies Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Neoantigen Targeted Therapies Revenue Market Share by Countries in 2018

Figure Saudi Arabia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure UAE Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Egypt Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Nigeria Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure South Africa Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue (Million USD) by Type (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue Share by Type (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Share by Type (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Share by Type in 2018

Table Global Neoantigen Targeted Therapies Revenue Forecast by Type (2019-2024)

Figure Global Neoantigen Targeted Therapies Market Share Forecast by Type (2019-2024)

Figure Global Monotherapy Revenue Growth Rate (2014-2019)

Figure Global Combination Therapy Revenue Growth Rate (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue by Application (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue Share by Application (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Share by Application (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Share by Application in 2018

Table Global Neoantigen Targeted Therapies Revenue Forecast by Application (2019-2024)

Figure Global Neoantigen Targeted Therapies Market Share Forecast by Application (2019-2024)

Figure Global Medical Research Institution Revenue Growth Rate (2014-2019)

Figure Global Hospital and Clinic Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Neoantigen Targeted Therapies Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Neoantigen Targeted Therapies Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

Figure Europe Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

Figure South America Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Bavarian Nordic

Neon Therapeutics

Immunicum

Genocea Biosciences

MediGene

Gradalis

Iovance Biotherapeutics

Immunovative Therapies

Company Profile

Company Profile Title

Description

Scope of the Report:

The global Neoantigen Targeted Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neoantigen Targeted Therapies.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Neoantigen Targeted Therapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neoantigen Targeted Therapies market by product type and applications/end industries.

Market Segment by Companies, this report covers

Bavarian Nordic

Neon Therapeutics

Immunicum

Genocea Biosciences

MediGene

Gradalis

Iovance Biotherapeutics

Immunovative Therapies

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monotherapy

Combination Therapy

Market Segment by Applications, can be divided into

Medical Research Institution

Hospital and Clinic

Other

READ MORE

Scope

Table of Contents

1 Neoantigen Targeted Therapies Market Overview

1.1 Product Overview and Scope of Neoantigen Targeted Therapies

1.2 Classification of Neoantigen Targeted Therapies by Types

1.2.1 Global Neoantigen Targeted Therapies Revenue Comparison by Types (2019-2024)

1.2.2 Global Neoantigen Targeted Therapies Revenue Market Share by Types in 2018

1.2.3 Monotherapy

1.2.4 Combination Therapy

1.3 Global Neoantigen Targeted Therapies Market by Application

1.3.1 Global Neoantigen Targeted Therapies Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Medical Research Institution

1.3.3 Hospital and Clinic

1.3.4 Other

1.4 Global Neoantigen Targeted Therapies Market by Regions

1.4.1 Global Neoantigen Targeted Therapies Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neoantigen Targeted Therapies Status and Prospect (2014-2024)

1.5 Global Market Size of Neoantigen Targeted Therapies (2014-2024)

2 Company Profiles

2.1 Bavarian Nordic

2.1.1 Business Overview

2.1.2 Neoantigen Targeted Therapies Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bavarian Nordic Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.2 Neon Therapeutics

2.2.1 Business Overview

2.2.2 Neoantigen Targeted Therapies Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Neon Therapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.3 Immunicum

2.3.1 Business Overview

2.3.2 Neoantigen Targeted Therapies Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Immunicum Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.4 Genocea Biosciences

2.4.1 Business Overview

2.4.2 Neoantigen Targeted Therapies Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Genocea Biosciences Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.5 MediGene

2.5.1 Business Overview

2.5.2 Neoantigen Targeted Therapies Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 MediGene Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.6 Gradalis

2.6.1 Business Overview

2.6.2 Neoantigen Targeted Therapies Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Gradalis Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.7 Iovance Biotherapeutics

2.7.1 Business Overview

2.7.2 Neoantigen Targeted Therapies Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

2.8 Immunovative Therapies

2.8.1 Business Overview

2.8.2 Neoantigen Targeted Therapies Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Immunovative Therapies Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

3 Global Neoantigen Targeted Therapies Market Competition, by Players

3.1 Global Neoantigen Targeted Therapies Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Neoantigen Targeted Therapies Players Market Share

3.2.2 Top 10 Neoantigen Targeted Therapies Players Market Share

3.3 Market Competition Trend

4 Global Neoantigen Targeted Therapies Market Size by Regions

4.1 Global Neoantigen Targeted Therapies Revenue and Market Share by Regions

4.2 North America Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.3 Europe Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.5 South America Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

5 North America Neoantigen Targeted Therapies Revenue by Countries

5.1 North America Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

5.2 USA Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

5.3 Canada Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

5.4 Mexico Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6 Europe Neoantigen Targeted Therapies Revenue by Countries

6.1 Europe Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

6.2 Germany Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.3 UK Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.4 France Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.5 Russia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

6.6 Italy Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Neoantigen Targeted Therapies Revenue by Countries

7.1 Asia-Pacific Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

7.2 China Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.3 Japan Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.4 Korea Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.5 India Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

8 South America Neoantigen Targeted Therapies Revenue by Countries

8.1 South America Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

8.2 Brazil Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

8.3 Argentina Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

8.4 Colombia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Neoantigen Targeted Therapies by Countries

9.1 Middle East and Africa Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

9.2 Saudi Arabia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.3 UAE Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.4 Egypt Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.5 Nigeria Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

9.6 South Africa Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

10 Global Neoantigen Targeted Therapies Market Segment by Type

10.1 Global Neoantigen Targeted Therapies Revenue and Market Share by Type (2014-2019)

10.2 Global Neoantigen Targeted Therapies Market Forecast by Type (2019-2024)

10.3 Monotherapy Revenue Growth Rate (2014-2024)

10.4 Combination Therapy Revenue Growth Rate (2014-2024)

11 Global Neoantigen Targeted Therapies Market Segment by Application

11.1 Global Neoantigen Targeted Therapies Revenue Market Share by Application (2014-2019)

11.2 Neoantigen Targeted Therapies Market Forecast by Application (2019-2024)

11.3 Medical Research Institution Revenue Growth (2014-2019)

11.4 Hospital and Clinic Revenue Growth (2014-2019)

11.5 Other Revenue Growth (2014-2019)

12 Global Neoantigen Targeted Therapies Market Size Forecast (2019-2024)

12.1 Global Neoantigen Targeted Therapies Market Size Forecast (2019-2024)

12.2 Global Neoantigen Targeted Therapies Market Forecast by Regions (2019-2024)

12.3 North America Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.4 Europe Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.6 South America Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Figure

List of Tables and Figures

Figure Neoantigen Targeted Therapies Picture

Table Product Specifications of Neoantigen Targeted Therapies

Table Global Neoantigen Targeted Therapies and Revenue (Million USD) Market Split by Product Type

Figure Global Neoantigen Targeted Therapies Revenue Market Share by Types in 2018

Figure Monotherapy Picture

Figure Combination Therapy Picture

Table Global Neoantigen Targeted Therapies Revenue (Million USD) by Application (2014-2024)

Figure Neoantigen Targeted Therapies Revenue Market Share by Applications in 2018

Figure Medical Research Institution Picture

Figure Hospital and Clinic Picture

Figure Other Picture

Table Global Market Neoantigen Targeted Therapies Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (2014-2024)

Table Bavarian Nordic Basic Information, Manufacturing Base and Competitors

Table Bavarian Nordic Neoantigen Targeted Therapies Type and Applications

Table Bavarian Nordic Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Neon Therapeutics Basic Information, Manufacturing Base and Competitors

Table Neon Therapeutics Neoantigen Targeted Therapies Type and Applications

Table Neon Therapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Immunicum Basic Information, Manufacturing Base and Competitors

Table Immunicum Neoantigen Targeted Therapies Type and Applications

Table Immunicum Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Genocea Biosciences Basic Information, Manufacturing Base and Competitors

Table Genocea Biosciences Neoantigen Targeted Therapies Type and Applications

Table Genocea Biosciences Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table MediGene Basic Information, Manufacturing Base and Competitors

Table MediGene Neoantigen Targeted Therapies Type and Applications

Table MediGene Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Gradalis Basic Information, Manufacturing Base and Competitors

Table Gradalis Neoantigen Targeted Therapies Type and Applications

Table Gradalis Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Iovance Biotherapeutics Basic Information, Manufacturing Base and Competitors

Table Iovance Biotherapeutics Neoantigen Targeted Therapies Type and Applications

Table Iovance Biotherapeutics Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Immunovative Therapies Basic Information, Manufacturing Base and Competitors

Table Immunovative Therapies Neoantigen Targeted Therapies Type and Applications

Table Immunovative Therapies Neoantigen Targeted Therapies Revenue, Gross Margin and Market Share (2017-2018)

Table Global Neoantigen Targeted Therapies Revenue (Million USD) by Players (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue Share by Players (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Share by Players in 2017

Figure Global Neoantigen Targeted Therapies Revenue Share by Players in 2018

Figure Global Top 5 Players Neoantigen Targeted Therapies Revenue Market Share in 2018

Figure Global Top 10 Players Neoantigen Targeted Therapies Revenue Market Share in 2018

Figure Global Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue (Million USD) by Regions (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue Market Share by Regions (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Market Share by Regions (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Market Share by Regions in 2018

Figure North America Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Europe Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure South America Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table North America Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

Table North America Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure North America Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure North America Neoantigen Targeted Therapies Revenue Market Share by Countries in 2018

Figure USA Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Canada Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Mexico Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table Europe Neoantigen Targeted Therapies Revenue (Million USD) by Countries (2014-2019)

Figure Europe Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure Europe Neoantigen Targeted Therapies Revenue Market Share by Countries in 2018

Figure Germany Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure UK Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure France Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Russia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Italy Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Neoantigen Targeted Therapies Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Neoantigen Targeted Therapies Revenue Market Share by Countries in 2018

Figure China Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Japan Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Korea Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure India Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table South America Neoantigen Targeted Therapies Revenue by Countries (2014-2019)

Table South America Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure South America Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure South America Neoantigen Targeted Therapies Revenue Market Share by Countries in 2018

Figure Brazil Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Argentina Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Colombia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Neoantigen Targeted Therapies Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Neoantigen Targeted Therapies Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Neoantigen Targeted Therapies Revenue Market Share by Countries in 2018

Figure Saudi Arabia Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure UAE Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Egypt Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure Nigeria Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Figure South Africa Neoantigen Targeted Therapies Revenue and Growth Rate (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue (Million USD) by Type (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue Share by Type (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Share by Type (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Share by Type in 2018

Table Global Neoantigen Targeted Therapies Revenue Forecast by Type (2019-2024)

Figure Global Neoantigen Targeted Therapies Market Share Forecast by Type (2019-2024)

Figure Global Monotherapy Revenue Growth Rate (2014-2019)

Figure Global Combination Therapy Revenue Growth Rate (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue by Application (2014-2019)

Table Global Neoantigen Targeted Therapies Revenue Share by Application (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Share by Application (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue Share by Application in 2018

Table Global Neoantigen Targeted Therapies Revenue Forecast by Application (2019-2024)

Figure Global Neoantigen Targeted Therapies Market Share Forecast by Application (2019-2024)

Figure Global Medical Research Institution Revenue Growth Rate (2014-2019)

Figure Global Hospital and Clinic Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Figure Global Neoantigen Targeted Therapies Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Neoantigen Targeted Therapies Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Neoantigen Targeted Therapies Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

Figure Europe Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

Figure South America Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Neoantigen Targeted Therapies Revenue Market Forecast (2019-2024)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Bavarian Nordic

Neon Therapeutics

Immunicum

Genocea Biosciences

MediGene

Gradalis

Iovance Biotherapeutics

Immunovative Therapies